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ABSTRACT 
ESTIMATION OF TOTAL CARCINOGENIC RISK DUE TO 
MULTIPATHWAY EXPOSURE TO TRIHALOMETHANES IN İZMİR 
DRINKING WATER  
The goal of this study was to investigate the cumulative and total carcinogenic 
risk levels of trihalomethanes (THMs) in İzmir drinking water by considering multi 
exposure routes and pathways. Drinking water THM concentrations measured and 
questionnaire data collected by Kavcar (Assessment of Exposure and Risk Associated 
with Trihalomethanes and Other Volatile Organic Compounds in Drinking Water, MSc 
Thesis, İYTE, 2005) were used for the exposure – risk assessment. Ingestion of drinking 
water, inhalation and dermal absorption during showering, bathing, hand washing, and 
dish washing were the considered exposure pathways. 
THM concentrations in air were estimated by using chemical specific transfer 
efficiencies. Chemical specific skin permeability coefficients and body surface areas 
were used . The contributions of exposure routes to the total risk, in the order of low to 
high, were dermal absorption, ingestion, and inhalation. 
Cumulative and total cancer risks were estimated using two different methods: 
commonly employed simple addition method and recently proposed Cumulative 
Relative Potency Factors (CRPF) approach. The total carcinogenic risks estimated by 
the both methods were acceptable (<1×10-6) in the minimum and lower bound exposure 
scenarios, generally acceptable (1×10-6 - 1×10-4) in the central tendency exposure 
scenario, and not acceptable (>1×10-4) in the upper bound and maximum exposure 
scenarios while simple addition produced an order magnitude higher risk levels 
compared to the CRPF method. The results of this study show that carcinogenic risks 
may be overestimated by using simple addition method.  Nevertheless, risk mitigation 
measures are needed by the local water authorities. 
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ÖZET 
İZMİR İÇME SUYUNDAKİ TRİHALOMETANLARA ÇOKYOLLU 
MARUZİYET SONUCU OLUŞAN TOPLAM KANSER RİSKİNİN 
BELİRLENMESİ 
Bu çalışmanın amacı, çeşitli maruziyet yollarını içerecek şekilde, İzmir içme 
suyunda trihalometanların (THM) kümülatif ve toplam kanserojen risk seviyelerini 
araştırmaktır. Maruziyet ve risk değerlendirilmesinde, Kavcar (Assessment of Exposure 
and Risk Associated with Trihalomethanes and Other Volatile Organic Compounds in 
Drinking Water, MSc Thesis, İYTE, 2005)  tarafından içme suyunda ölçülen THM 
konsantrasyonları ve anket sonuçları kullanılmıştır. Maruziyet kaynakları olarak içme 
suyunun tüketimi, duş, banyo, el yıkama ve bulaşık yıkama sırasında soluma ve deri ile 
etkileşim düşünülmüştür. 
İçme suyunda bulunan THM konsantrasyonu ölçülmüş değerlerdir. Havada 
bulunan THM konsantrasyonu ise kimyasallara özgü transfer etki katsayıları 
kullanılarak hesaplanmıştır. Deri maruziyetlerinin hesaplanmasında kimyasala özgü deri 
geçirgenlik katsayıları ve vücut yüzey alanları kullanılmıştır. Maruziyet yollarının 
toplam riske katkısını düşükten yükseğe doğru dizecek olursak deri, yeme ve soluma 
şeklide olmaktadır. 
Kümülatif ve toplam kanser riski 2 farklı metot ile hesaplanmıştır. Bunlar; 
genellikle uygulanan basit toplama metodu ve son zamanlarda yayınlanan Kümülatif 
İlgili Potansiyel Faktör (CRPF) yaklaşımıdır. Her iki yöntem ile uygulanan toplam 
kanser riski en düşük ve alt seviye senaryolar için kabul edilebilir (<1×10-6) seviyededir. 
Ortalama senaryosu için genel kabul edilebilir (1×10-6 - 1×10-4) seviyededir. En yüksek 
ve üst seviye senaryolar için kabul edilemez (>1×10-4) seviyededir. Basit toplama 
yöntemi CRPF yönetimi ile karşılaştırıldığında daha yüksek risk seviyelerini 
göstermektedir. Bu çalışmanın sonucu bize basit toplama yönteminin, riskleri daha 
yüksek seviyelerde göstereceğini anlatmıştır. Buna rağmen, yerel otoritelerin riski 
azaltıcı önlenmelere ihtiyaçları vardır. 
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CHAPTER 1 
INTRODUCTION 
The use of chlorine in the treatment of drinking water has virtually eliminated 
waterborne diseases, because chlorine can kill or inactivate most microorganisms 
commonly found in water. However, the use of chlorine can lead to the formation of 
disinfection by-products (DBP) such as THMs (Stiteler et al., 2000). Trihalomethanes 
(THMs) are a group of compounds which are formed in drinking-water primarily as a 
result of chlorination of organic matter present naturally in raw water supplies (e.g., 
decaying leaves and vegetation). 
Volatile organic compounds such as THMs have adverse health effects. Liver 
and kidney damage, immune system, nervous system, reproductive system and several 
types of cancers may occur because of exposure to drinking water containing volatile 
organic compounds (VOC). Also the exposure to DBPs increases the risk of bladder, 
colon-rectum, leukemia, stomach and rectal cancers as well as abortion, birth weight 
and birth defects (Cantor 1997, Calderon 2000). Chloroform (CHCl3) is the most 
common THM, detected in the greatest concentrations in water. The U.S. 
Environmental Protection Agency (USEPA) has classified chloroform as a probable 
human  carcinogen (http://www.epa.gov/iris).  High dose of chloroform is a carcinogen 
(Lévesque et al., 2000). However, chloroform is not likely to be carcinogenic to humans 
by any route of exposure under exposure conditions that do not cause cytotoxicity and 
cell regeneration (Nazir et al., 2005). Eventually, USEPA has withdrawn ingestion 
carcinogenic potency factor for chloroform because its levels are generally low in 
drinking water (http://www.epa.gov/iris).  
The trihalomethanes consists of chloroform (CHCl3), bromodichloromethane 
(BDCM), dibromochloromethane (DBCM), and bromoform (CHBr3).  It is assumed that 
the primary exposure route to THMs is ingestion. However, THMs are volatile organic 
compounds and may be transferred to air, depending on the environmental conditions, 
which results in inhalation and dermal exposures. Drinking water exposure to THMs 
may occur by four pathways: 
• Ingestion of drinking-water,  
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• Inhalation of indoor air largely due to volatilization from drinking-water,  
• Inhalation and dermal exposure during showering or bathing  
• Ingestion of food, with all but food exposure arising primarily from drinking-
water  
Exposure assessment is a main component of the risk assessment process. Exposure to 
THMs depends on human activity and water use patterns and DBP concentrations in 
water. After exposure, pharmacokinetics and pharmacodynamics determines the dose. 
Pharmacokinetics incorporates information on organ volumes, organ-specific blood 
flows and metabolic capacity. Generally, no pharmacokinetic interactions among 
mixture components are assumed (Teuschler et al., 2004).  Figure 1.1 shows the 
relations among pollutant concentrations, exposure, and dose. 
 
 
 
Figure 1.1. Dose Metrics for Environmental Concentrations  
(Source: Teuschler et al., 2004) 
 
Dose can be measured by four different ways. In the body, there are exchange 
boundaries such as skin, lung and intestinal tract. (1) Route-Specific Exposure occurs 
when that amount of a chemical available to pass the boundary. (2) Route-Specific 
Absorbed Dose is the amount of a chemical which is absorbed from a single exposure 
route. (3) Total Absorbed Dose is the amount of a chemical which is absorbed from all 
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exposure routes. For example, amount of chemical in blood. (4) Organ or Tissue Doses 
are the amount of a contaminant in an organ or tissue (Teuschler et al., 2004), which 
causes the health effect. 
Risk is determined for individual chemicals. Aggregate exposure and risk 
assessment involve the analysis of exposure to a single chemical by multiple pathways 
and routes of exposure. Cumulative exposure and risk involve assessment for multiple 
chemicals in a mixture over one exposure route.  Aggregation of cumulative exposure-
risk over multiple exposure routes results in the total risk.  Generally to calculate 
cumulative risk in a mixture, the risk of contaminants for each route is simply added 
together. This approach is called Simple Additive Method.  
Complex mixtures such as those resulting from disinfection of drinking water 
supplies present a difficult problem for risk assessors because of the large number of 
components. The concentration of each individual component may be small enough to 
pose no threat, but if they act jointly in some additive or greater than additive manner, 
then there may be some concern for health safety (Krishnan et al., 1997). To calculate 
cumulative risk for a mixture, simple addition can only be applied if the mode of action, 
the mechanism of the health effect, is similar for individual components of the mixture. 
Teuschler et al. (2004) proposed a cumulative risk assessment method, the Cumulative 
Relative Potency Factors (CRPF) approach which combines exposure modeling and 
physiologically based pharmacokinetic modeling results. Carcinogenic risks of THMs 
for İzmir drinking water were estimated (Kavcar et al., 2006; Baytak et al., 2008) but 
for only ingestion route. This study aimed to estimate cumulative and total risk levels 
for THMs for İzmir drinking water using the approach proposed by Teuschler et al. 
(2004). 
This thesis includes seven chapters. Chapter 1 presents a brief introductory 
background to the research subject. Previous relevant studies are reviewed in Chapter 2. 
Carcinogenic risk assessment is presented in Chapter 3. Material and methods are 
described in Chapter 4. In Chapter 5, the results of CRPF approach is presented. The 
discussion of the study is summarized in Chapter 6. Finally, the main results and the 
conclusions of the study are followed by in Chapter 7. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1. THM Concentrations in Drinking Water 
THMs in drinking water have been widely studied throughout the world. 
Therefore there are many studies that report THM levels in drinking water from both 
Turkey and other countries. Since, the focus of this study is on the risk assessment for 
THMs only a brief review is presented here. 
 
2.1.1. THM Concentrations in Abroad and Turkey 
Legay et al. (2011) conducted a study to investigate THM concentrations in the 
regions of Québec and Lévis in Canada. Measured concentration ranges were reported 
as 14.1-155 g/L for chloroform; 1.21-10.8 g/L for BDCM; 0.2-3.34 g/L for DCBM; 
0.15-0.38 g/L for bromoform. Average Total THM (TTHM) concentrations were 
measured between 18.6 g/L and 158.2 g/L with standard deviations of 8.6 g/L and 
61.4 g/L, for Quebec and Levis regions, respectively (Legay et al., 2011). 
Lee et al. (2004) analyzed tap water samples from different locations in Hong 
Kong for THMs. TTHM levels measured in the study varied from 15.8 to 87.2 g/L. 
Chloroform was the major THM compound measured between 5.71 and 75.1 g/L (Lee 
et al., 2004). 
Tokmak et al. (2004) conducted a study in Ankara, Turkey. Tap water samples 
were collected seasonally from 22 different districts to observe occurrence of THMs. 
The statistics of concentrations were not reported, the following are based on the 
numbers extracted from the figures in the article. The average concentration for TTHM, 
chloroform, BDCM, the sum of DBCM and bromoform was about 45 g/L, 40 g/L, 4 
g/L, 1 g/L, respectively. The TTHM concentration of the water leaving the treatment 
plant was measured as 35 μg/L, while it was measured as 110 g/L at a sampling point 
in Konutkent district which is one of the furthest to the plant.  
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 Uyak (2005) reported THM concentrations in Istanbul at sampling points served 
by different water sources. Chloroform concentrations were between of 42 g/L and 12 
g/L; BDCM were between 30 g/L and 11 g/L; DBCM were between 33 g/L and 
6.7 g/L; and bromoform were between 11 g/L and 1 g/L.  The average measured 
concentrations are presented in Table 2.3. 
Two studies reported THM concentrations for İzmir drinking water. Kavcar et 
al. (2006) collected samples from 100 different sampling points throughout the 
province. Baytak et al. (2008) collected 44 samples at one point in the metropolitan area 
to determine seasonal variation.  The mean concentrations of chloroform, BDCM, 
DBCM, and bromoform were 4.41, 3.73, 2.61 and 0.62 μg/L, respectively, measured by 
Kavcar et al. (2006) with ranges from below detection limit to 35 μg/L for chloroform, 
28 μg/L for BDCM, 18 μg/L for DBCM, and 4 μg/L for bromoform. However, the 
average concentrations (and maximum values) were much higher due to seasonal effects 
22 (98), 15(66), 10(44), 5(20) μg/L for chloroform, DBCM, BDCM, and bromoform, 
respectively, as reported by Baytak et al. (2008). 
 
Table 2.1. Minimum and Maximum THM Concentrations Reported in the Literature 
 
Literature  
 
TTHM  
(g/L) 
Chloroform 
(g/L) 
BDCM (g/L) DBCM 
 (g/L) 
Bromoform 
(g/L) 
 Min Max Min Max Min Max Min Max Min Max 
Legay et al., 2011 
Québec 
region 
18.6 
 
158.2 14.1 155.9 1.21 9.4 0.2 3.34 0.17 0.38 
Lévis 
region 
26.3 72.9 19.7 64.2 2.65 10.8 0.24 1.65 0.15 0.33 
Lee et al., 2004 
Hong 
Kong 
15.80 87.20 5.71 75.1 5.04 17.2 0.83 5.56 0.04 0.92 
Uyak, 2005 
Istanbul 33 100 12 42 11 30 6,7 33 1 11 
Kavcar et al., 2006 
Izmir - - 3.84x10
-11
 34.58 1.58x10
-07
 27.45 4.09x10
-07
 13.48 2.02x10
-04
 4.19 
Baytak et al., 2008 
Izmir 2.86 183 0,03 98.39 0.01 43.82 0.19 65.91 0.04 19.13 
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2.2. Human Health Risk Levels Due to THMs in Drinking Water 
Legay et al. (2011) conducted a study in Canada. In the assessment of cancer 
risk, multi-exposure routes (ingestion, inhalation and dermal contact) were considered. 
Showering and bathing activities for inhalation and dermal exposure; drinking water for 
ingestion exposure was included. Total carcinogenic risk was estimated by simple 
addition of carcinogenic risks of THM species. Since there was a debate over 
carcinogenity of chloroform, the risks were estimated with and without chloroform. 
Total carcinogenic risk was calculated by simple addition method. All total 
cancer risk (RT) values were >10
-6
, greater than the acceptable carcinogenic risk level, 
when chloroform was included in the assessment.  On the other hand, carcinogenic risk 
assessment without chloroform resulted in 5
th
 and 50
th
 percentile values of <5.10
-5
. 
Whereas the 95
th
 percentile value ranged between 5.10
-5
 and 10
-4 
in different zones 
(Legay et al., 2011). 
Lee et al. (2004) estimated cancer and chronic-toxic risks due to THMs in tap 
water in Hong Kong. All three routes (ingestion, inhalation, and dermal) were 
considered. Total carcinogenic risk was calculated by simple addition method. Their 
results indicated that ingestion was the most important route. The average lifetime 
cancer risks were ranked in descending order as BDCM, chloroform, DBCM, and 
bromoform for ingestion route with percentage contributions of 59, 24, 17, and 0 to the 
total risk, respectively. In all districts studied in Hong Kong, cancer risk for bromoform 
was <10
–6
, whereas the risk levels for the other THM species exceeded this level. The 
lifetime cancer risks calculated for TTHMs were in the range 4.5x10
-5
 - 1.15x10
-4
 with 
an average value of 7.55x10
-5
. Table 2.4. presents the risk values reported in the 
literature. 
Uyak (2005) conducted a multi-route exposure–risk assessment study in 
Istanbul. Total risk was calculated by the simple addition method.  Istanbul residents 
had a higher risk of cancer through ingestion route. The lifetime cancer risks through 
oral ingestion of chloroform, BDCM, and DBCM in tap water of all the sampled 
districts were higher than 10
-6
. 
Tokmak et al. (2004) estimated multi-route carcinogenic risk and calculated total 
risk levels by simple addition for THMs in Ankara. The average lifetime cancer risk of 
about 1.2×10-5 caused by chloroform was almost 12 times higher than the acceptable 
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risk level of 10
-6
. Total carcinogenic risk values were extracted from the illustrations in 
the article. The average risk was approximately 1.4×10-5. The highest cancer risk was 
due to firstly ingestion, secondly inhalation and lastly dermal route (Tokmak et al., 
2004). 
 
Table 2.2. Average Cancer Risk Reported in the Studies 
 
Literature  TTHM  Hazard Index 
Lee et al., 2004 
 Male Female Male Female 
Hong Kong 9.76x10
-5
 9.60×10-5 3.45×10-1 3.45×10-1 
Uyak., 2005 
Istanbul 1.13×10-4 1.18×10-4 1.81×10-1 1.87×10-1 
Kavcar et al., 2006* 
Izmir 1,33x10
-5
 0,0229 
*Hazard Index and TTHM were only calculated for ingestion route. 
 
Multi-pathway evaluations of noncarcinogenic risks for THMs were calculated 
by using the hazard index. Hazard index of THMs is obtained through oral route and 
dermal absorption (Lee et al., 2004). 
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Table 2.3. Average Hazard Index for THM Reported in the Studies 
 
 Hazard Index For THMs 
Literatur
e  
 
Oral Route Dermal Route for 
Male 
Dermal Route for 
Female 
Inhalation* 
Lee et 
al., 2004 
Min Max Min Max Min Max Min Max 
Hong 
Kong 
6.89×10-2 5.19×10-1 2.87×10-6 1.10×10-5 2.5×10-6 9.6×10-6 1.00×10-6 1.50×10-5 
 Oral Route for male Dermal Route for 
Male 
Dermal Route for 
Female 
Inhalation** 
Uyak., 
2005 
Min Max Min Max Min Max Min Max 
Istanbul 6.43×10-2 1.85×10-1 2.49×10-2 7.9×10-2 2.34×10-2 6.75×10-2 - - 
* Non-cancer risk is only carried out for chloroform compound not for THMs. Because of its property of 
a lower boiling point, chloroform is assumed to be the major compound 
**Hazard Index was not calculated for inhalation route. 
 
Kavcar et al. (2006) and Baytak et al. (2008) estimated the risks for only 
ingestion route drinking water pathway. The mean deterministic noncarcinogenic risk 
(hazard quotient) for chloroform, BDCM, DBCM, and bromoform was 0.0128, 0.0054, 
0.0038, and 0.0009, respectively. HQ values greater than 1 indicate a potential for an 
adverse effect to occur or the need for further study. For İzmir drinking water, however, 
the calculated HQ values pointed out negligible noncarcinogenic risks. The mean 
deterministic carcinogenic risk was estimated for the metropolitan area as 6.74×10-6, for 
BDCM; 6.46×10-6 for DBCM; and 1.46×10-7 for bromoform. Chloroform was not 
included because USEPA had withdrawn its potency factor.  The carcinogenic risks 
were higher when seasonal variations in the THM concentrations were considered 
(Baytak et al., 2008). The mean carcinogenic risk values were 2.5×10-5, 3.5×10-5, and 
6.6×10-6 for BDCM, DBCM, and bromoform, respectively. 
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CHAPTER 3 
CARCINOGENIC RISK ASSESSMENT 
 This chapter defines different types of carcinogenic risk which are risk, 
aggregate risk, cumulative risk, and total risk. 
Risk is defined as the risk of one component for one exposure route. Aggregate 
risk is defined as the total risk of one component obtained by summing risks of each 
exposure route.  Cumulative risk is obtained when the risks of all components in a 
mixture for one exposure route.  Total risk is obtained when the cumulative risks are 
summed up over all exposure routes. USEPA uses a general acceptable risk value 
(1.0×10-6) for environmental pollutants.  However, depending on the state-of-the-art 
with regards to sampling/analytical techniques and control technologies, higher levels 
can be assumed as in the case of acceptable carcinogenic risk for arsenic (1.0×10-4). 
Recently, Legay et al. (2011) categorized total risks as no action is needed (RT< 10
-6
). 
General acceptable levels (10
-6≤ RT < 5.10
-5
), low priority (5.10
-5≤ RT < 10
-4
), and 
unacceptable, action required (RT ≥10
-4
). 
 
3.1. Common Approach to Cumulative Risk – Simple Addition  
 Risks estimated for each component of a mixture is summed up to calculate 
cumulative and then total risks (Legay et al., 2011; Lee et al., 2004; Tokmak et al., 2004; 
Uyak, 2006).  The equation for total carcinogenic risk is given below (Eq. 3.1).  
 
(3.1) 
 
where, 
R = Risk 
i = Polutant 
j = Route 
Rij
10 
3.2. Alternative Approach to Cumulative Risk- Cumulative Relative 
       Potency Factors 
 The Cumulative Relative Potency Factors (CRPF) approach as the mixtures risk 
assessment method was proposed by Teuschler et al. (2007), and a case study was 
illustrated for THMs. CRPF approach uses two different methods to estimate 
cumulative risk: dose addition and response addition. 
In a mixture, there are different pairs of components. If there is a common mode 
of action or no interactions between the components, the definition of additivity may be 
appropriate. Dose addition and response addition depends on the toxicity similarity of 
chemicals.  
 
3.2.1. Mode of Action (MOA) 
 For chemical mixtures, defining the similarity of toxic action has become an 
important first step in the risk assessment process. Substances, that cause a common 
toxic effect(s) by the same, or essentially the same mechanism, have the same Mode of 
Action.  The subclasses that have different MOA, they are assumed to cause toxicity 
independently of each other. Mode of action means the knowledge of molecular and 
cellular events leading to a toxicological outcome. A toxicological outcome is 
considered as damaging to the organism at any level of biological organization (i.e., 
molecular, cellular, tissue, etc.) (Teuschler et al., 2004). 
Dose addition and response addition methods can be integrated to assess risk. To 
estimate the risk of each subclass, the mixture's components are categorized into 
subclasses of the same MOA. Therefore the risk of each subclass can be estimated 
based on Relative Potency Factors (RPF) approach. The subclass risks can be added to 
yield the total mixture risk of causing the same health outcome (Teuschler, 2007). 
 
3.2.2. Index Chemical 
 The index chemical, which is a component in the mixture, must have a clearly 
defined and high quality dose-response relationship and data. For the effect and route of 
concern, that component also has the same mode of action as the other members of the 
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subclass.  For each subclass, the strength and completeness of the components’ toxicity 
data is to be evaluated to identify an index chemical. 
 
3.2.3. Dose Addition 
 The risk from exposure to multiple chemicals acting via a common MOA may 
be assessed using the summed doses of the individual chemicals scaled for relative 
potency. The dose addition is recommended for the components in a mixture that show 
similar toxicity (Choudhury et al., 1999). 
 
3.2.4. Response Addition 
 The risk from multiple chemicals acting via independent MOA may be assessed 
by summing the probabilistic risks of response from exposure to the individual 
chemicals. The response addition is recommended for the components chemicals in a 
mixture that show dissimilar toxicity. To apply the dose addition or response addition 
method, lower exposure levels and no interaction information should be available 
(Choudhury et al., 1999). 
 
3.2.5. ICED (Index Chemical Equivalent Doses) 
ICED combines dose addition and response addition into one method. The 
Cumulative Relative Potency Factors (CRPF) approach use chemical mixture which has 
common mode of action subclasses. That means toxicological outcome is the same. For 
each subclass, an index chemical is selected. In our study there is one subclass that is 
THMs. First of all, the highest quality mode of action data is selected. 
Dichlorobromomethane (BDCM) is selected as index chemical as suggested by 
Teuschler (2004). Index Chemical Equivalent Dose (ICED) is calculated by using a 
Relative Potency Factor (RPF). Component ICED is the ICED for an individual 
chemical in a subclass. Subclass ICED is calculated by summing their component 
ICEDs (Figure 3.1). 
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Figure 3.1. Illustration of CRPF Approach for Illustration of DBP Mixture Cancer Risk 
(Source: Teuschler et al., 2004) 
 
 RPF(s) are calculated by the ratio of slope factors. Slope factor of a chemical is 
divided to slope factor of the index chemical. 
 
RPF= SFcomponent / SFindex chemical                                                     (3.4) 
 
The absorbed dose for each DBP is multiplied by its RPF. Therefore a 
component ICED for each member of the subclass is calculated. 
 
Component ICED = RPF × Total Absorbed Dose of Component       (3.5) 
 
Sum of component ICEDs is used for obtain subclass ICED. 
 
Subclass ICED = Component1 ICED + Component2 ICED +…+ Componentn ICED 
    (3.6) 
     Subclass Risk = MLE Slope Factor × Subclass ICED      (3.7) 
 
   Total Mixture Risk = Subclass Risk1 + Subclass Risk2 + … + Subclass Riskn     (3.8) 
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The approach for calculating subclass ICED is the dose addition, since the mode 
of action of each component is the same in the subclass. On the other hand, to calculate 
the total mixture risk, the approach is the response addition, because the subclasses 
risks, which have different mode of action, are summed together. 
CRPF approach is also implemented to multiple exposure routes. CRPF analysis 
is conducted to separate exposures for each route. Ingestion, inhalation and dermal 
exposures are considered in the calculation. 
CRPF approach is suitable for components which has cancer end point. 
Carcinogens are divided into two classes that are genotoxic and non-genotoxic. 
Chloroform is not likely to be carcinogenic to humans by any route of exposure under 
exposure conditions that do not cause cytotoxicity and cell regeneration. USEPA has 
withdrawn the cancer potency factor for chloroform because its levels are generally low 
in drinking water. Bromodichloromethane and bromoform are probable human 
carcinogens; dibromochloromethane is a possible human carcinogen 
(http://www.epa.gov/iris). Choloroform is non-genotoxic; while BDCM, DBCM, and 
bromoform are genotoxic (see Table 3.1). 
 
Table 3.1. Carcinogenty Class of DBP  
(Source: IRIS, 2005) 
 
DBP Toxicity Carcinogenity 
Bromodichloromethane (BDCM) Genotoxic Probable human carcinogen 
Dibromochloromethane (DBCM)   Genotoxic Possible human carcinogen 
Bromoform (CHBr3) Genotoxic Probable human carcinogen 
Chloroform (CHCl3) Non-Genotoxic Probable human carcinogen 
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CHAPTER 4 
MATERIAL AND METHOD 
4.1. Characteristics of Studied Participants 
 In this study, THM concentrations (measured in tap water samples collected 
from homes in metropolitan area of İzmir) and time-activity data (collected by 
administering questionnaires to a participant from each sampled home) collected by 
Kavcar (Assessment of Exposure and Risk Associated with Trihalomethanes and Other 
Volatile Organic Compounds in Drinking Water, MSc Thesis, İYTE, 2005) were used 
for cumulative risk assessment of THMs in drinking water. Participants were from the 
district of Güzelbahçe (1%), Balçova (3%), Gaziemir (3%), Narlıdere (3%), Çiğli (4%), 
Buca (13%), Bornova (18%), Karşıyaka (19%) and Konak (34%). Drinking water 
samples were analyzed for VOCs using an automated headspace sampler followed by a 
gas chromatograph (GC). The GC was equipped with a mass spectrometry (MS) 
detector to identify and quantify VOCs.  
For each sampling unit, one person was asked to be the primary participant and 
administer the questionnaires. The first questionnaire, which inquired about 
demographics of occupants, was administered by the investigators during the visit. The 
second questionnaire was self-administered by the primary participant. Data collected 
from questionnaires such as body weight and daily intake rate, the two most important 
parameters to be used  in estimating chronic daily exposure, were helpful in predicting 
more accurate risk levels compared to making assumptions, as usually practiced in risk 
assessment studies. Other key data included gender, age, education and income level, 
and homeland which made comparison of exposure and risk for different subgroups 
possible. The participants were also asked to provide information regarding activities 
that determine inhalation and dermal exposure to THMs, such as showering/bathing, 
dish washing, hand washing, etc. Details regarding materials and methods can be found 
elsewhere (Kavcar et al., 2006). Only a small portion of the participants (32) provided 
extended questionnaires, therefore this study was based on the data obtained for/from 
these participants.  Information regarding participant characteristics are presented in 
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Table 4.1 and 4.2.  Descriptive statistics for the measured concentrations (Table 4.3) 
and concentration frequency histograms (Figures 4.1 – 4.4) are also presented. 
 
Table 4.1. Descriptive Statistics for Participant Characteristics – Gender 
 
Gender Number Percentage 
Female 21 %66 
Male 11 %34 
 
 
Table 4.2. Descriptive Statistics for Participant Characteristics - Age and Weight 
 
 Median Mean SD Min Max 95
th
 
percentile 
Age 28 33 12,6 16 67 52.2 
Weight 
(kg) 
67 66 14,4 47 96 87 
 
 
Table 4.3. Descriptive Statistics for Measured THM Concentrations (g/L)* 
 
 Median Mean SD Min Max 95
th
 
percentile 
Chloroform 0.10 7.65 12.1 3.84×10
-11 34.6 29.9 
BDCM 0.13 6.29 9.82 4.76×10
-6 27.5 24.6 
DBCM 0.42 4.31 6.32 3.24×10
-4 17.2 15.3 
Bromoform 0.45 0.98 0.10 3.97×10
-3 3.22 2.5 
*Censored concentrations, see Kavcar et al. (2006) for the censoring method 
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Figure 4.1. Distrubution of Chloroform Concentrations 
 
 
 
 
Figure 4.2. Distrubution of Dichlorobromomethane Concentrations 
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Figure 4.3. Distrubution of Chlorodibromomethane Concentrations 
 
 
 
 
Figure 4.4. Distrubution of Bromoform Concentrations 
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4.2. Exposure Data 
For each route, exposure pathways considered in this study, are shown in Table 
4.4.  Time-activity data related to these pathways are presented in Table 4.5.  Drinking 
water intake rate data are presented in Table 4.6. 
 
Table 4.4. Routes and Pathways Considered in this Study 
 
Route 
 
 
Pathway 
Ingestion Inhalation Dermal 
Drinking Water  
(L/day) 
● - - 
Hand Wash  
(min) 
- ● ● 
Dish Washing  
(min) 
- ● ● 
Showering  
(min) 
- ● ● 
Bath  
(min) 
- ● ● 
 
 
Table 4.5. Descriptive Statistics for Time-Activity Data 
 
 Median Mean SD Min Max 95
th
 
percentile 
Hand Wash (min) 9 10.9 5.5 4 31 21.8 
Dish Washing 
(min) 
20 30.1 54.4 0 309 52.8 
Showering (min) 18 20.3 9.7 0 54 34.4 
Bath (min) 0 16.7 24.2 0 110 47.4 
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Table 4.6. Descriptive Statistics for Drinking Water Intake Rates 
 
 Median Mean SD Min Max 95
th
 percentile 
Intake Rates (L/day) 1,4 1,6 0,9 0,4 4,5 31.2 
 
4.3. Risk Factors 
Values of the risk factors used in this study were obtained from the Integrated 
Risk Information System (IRIS), and are given in Table 4.7. 
 
Table 4.7. Risk Factor Values 
(Source: IRIS, 2005) 
 
DBP Slope Facor (SF) 
per(mg/kg)/day 
RPF=   
SFi/SFindex  
                 chemical 
Drinking Water 
Unit Risk  
per (g/L) 
Inhalation 
Unit Risk 
per 
(g/m3) 
Genotoxic Subclass 
Bromodichloromethane 
(BDCM) 
6.2 x10
-2
  =0.062/0.062 
=1 
1.8 x10
-6
 - 
Dibromochloromethane 
(DBCM)   
8.4 x10
-2
 =0.084/0.062 
=1.355 
2.4 x10
-6
 - 
Bromoform  
(CHBr3) 
7.9 x10
-3
 =0.0079/0.062 
=0.127 
2.3x10
-7
 1.1 x10
-6
 
Non-Genotoxic 
Chloroform  
(CHCl3) 
RfD:0.01 
(mg/kg/day) 
- - 2.3 x10
-5
 
 
4.4. Exposure Assessment  
In the calculation, five exposure scenarios were considered. These are; 
- Minimum Exposure Scenario: Minimum values of each input variable that 
would minimize the model output (exposure-risk) value are considered. 
- Lower Bound Scenario: 5th percentile values of each input variable are used 
- Central Tendency Scenario: The median value of each input variable to 
calculate a 50
th
 percentile exposure-risk value.   
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- Central Tendency Scenario: The median value of each input variable to 
calculate a 50
th
 percentile exposure-risk value.   
- Upper Bound Scenario: 95th percentile values of each input variable are used. 
- Maximum Exposure Scenario: Maximum values of each input variable that 
would maximize the model output (exposure-risk) value are considered. 
 
4.5. Exposure Factor 
Exposure factor can be calculated as fallows (ATSDR, 2005):  
AT
FxED
EF         (4.1) 
where, 
EF = Exposure factor (unitless) 
F = Frequency of exposure (days/year) 
ED = Exposure duration (years) 
AT = Averaging time for non-carcinogenic subtances (EDx365 days/years) 
AT = Averaging time for carcinogenic subtances (LTx365 days/years) 
LT =Life time (years) 
 
4.6. Exposure Dose Calculation 
The calculation of exposure dose depends on pathway of exposure. Therefore 
there are three kinds of exposure dose equation. 
 
4.6.1. Water Ingestion Exposure Dose Calculation 
Exposure dose because of ingestion can be calculated as (ATSDR, 2005); 
BW
CxIRxEF
D        (4.2) 
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where, 
D = Exposure dose (mg/kg/day) 
C = Contaminant concentration (mg/L) 
IR = Intake rate (L/day) 
EF = Exposure factor (unitless) 
BW = Body weight (kg) 
 
4.6.2. Air Inhalation Exposure Dose Calculation 
Exposure dose from inhalation of air can be calculated as (ATSDR, 2005); 
BW
CxIRxEF
D        (4.3) 
where, 
D = Exposure dose (mg/kg/day) 
C = Contaminant concentration (mg/m
3
) 
IR = Intake rate (m
3
/day) 
EF = Exposure factor (unitless) 
BW = Body weight (kg) 
 
4.6.2.1. Transfer Efficiency Calculation 
THMs present in water are ultimately transferred to air as a result of their 
volatility. The transfer efficiencies were determined experimentally by measurements of 
the chemical content of water entering and leaving the exposure area during activities 
(McKone, 1987). Chloroform is chosen as a base chemical because it is the most 
studied THM. Transfer efficiency to air from shower, from bathroom and from house 
for chloroform was reported as 0.65 (unitless) (Williams et al., 2002). The transfer 
efficiency of THMs other than chloroform is calculated under the assumption that the 
transfer efficiency is in proportion to overall mass-transfer coefficient K at the liquid 
gas boundary (McKone, 1987). 
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          2.5     RT 
  + 
                          K(j)             Dl 
2/3    
Da
2/3
H  Ch 
Φ i 
j = Φ i
Ch
 x    = Φ i
Ch 
     (4.4) 
                         K(Ch)     2.5     RT 
                          + 
                             Dl 
2/3    
Da
2/3
H  j 
 
 
(Source: McKone, 1987) 
Φ i 
j   
= transfer efficiency for species j for water use in compartment i, unitless  
Φ i
Ch 
= transfer efficiency for chloroform as derived from measurements for water 
use, in compartment i, 0.65 unitless. 
K = overall mass-transfer coefficient, m/s 
R  = gas constant, 0.00008205 L. atm/mo1.K   
T  = temperature, K 
H  = Henry’s law constant,  
D1  = the diffusion coefficient of the chemical in water, m
2
/s;  
Da = the diffusion coefficient of the chemical in air, m
2
/s; 
 
4.6.3. Water Dermal Contact Exposure Dose Calculation 
Exposure dose from dermal contact of water can be calculated as (ATSDR, 
2005); 
BW
xSAxETxCFCx
D
Kps
       (4.5) 
where, 
D = Dose (mg/kg/day) 
C = Contaminant concentration (mg/m
3
) 
Kps = Permeability coefficient (cm/hr) 
SA = Exposed body surface area (cm
2
) 
ET = Exposure time (hours/day) 
CF = Conversion factor (1L/1000 cm
3
) 
BW = Body weight (kg) 
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4.6.3.1. Body Surface Area 
To calculate dermal exposure dose, body surface area is a parameter calculated. 
The improved equation is to predict body surface area from a patient’s weight. Body 
surface area is calculated using the following equation (Edward et al., 2001). 
 
BSA= a×BWb          (4.6)  
 
where; 
BSA = Body surface area, 
a = Dimensionless coefficient, (0.1173) 
BW = Body weight in kilograms,  
b = Dimensionless scaling coefficient. (0.6466) 
 
4.7. Risk Assessment  
Non-carcinogenic risk is calculated using the following equation (USEPA 1999b);   
 
               (4.7)        
     
Hazard index (HI) is the sum of the HQ values for each of the mixture 
components (Eq. 4.9). When HQ or HI value for a mixture exceeds 1, it represents a 
concern of health risk (Krishnan et al., 1997). The hazard index does not define dose-
response relationships, and its numerical value should not be constructed to be a direct 
estimate of risk (USEPA 1986). 
 
          (4.8) 
 
HI: Hazard Index 
HQ: Hazard Quotient     
CDI: Chronic Daily Intake (mg/kg/d)  
RfD: Reference Dose (mg/kg/d)   
Carcinogenic risk is calculated using the following equation (USEPA 1999a); 
RfD
CDI
HQ 

N
nHQHI
1
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(4.9) 
 
R: Risk 
SF: Slope Factor (mg/kg/d)
-1
 
CDI: Chronic Daily Intake (mg/kg/d)  
According to ICED approach, risk is calculated using the following equation; 
 
Subclass Risk= MLE Slope Factor × Subclass ICED     
Total Mixture Risk= Subclass Risk1 + Subclass Risk2 + … + Subclass Riskn 
SFCDIR 
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CHAPTER 5 
RESULTS 
The processes of risk assessment include data collection, data evaluation, 
exposure assessment, toxicity assessment and risk characterization. Cancer risk 
assessment associated with exposure to THMs in drinking water through ingestion, 
inhalation and dermal exposure route was carried out for Izmir. As previously 
described, the calculation of risk was based on two methods: simple addition and ICED.  
Results of the assessment are presented in this chapter following with Discussions 
(Chapter 6). 
 
5.1. Results of the Exposure Factors’ Calculation 
The exposure factors were identified by determining of magnitude, duration, and 
frequency of exposure to the contaminants. There are some assumptions for calculation 
of exposure factor. These are; 
 
- Frequency of exposure of water by drinking water: 365 days/year 
- Exposure duration is equal to life time: 70 year male or female 
- Averaging time for carcinogenic substances is equal to life time: 70 years. 
 
Based on these assumptions the calculated exposure factor values are all unity 
for all five scenarios (Table 5.1). 
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Table 5.1. Calculated Exposure Factor Values 
 
 
 
 
Frequency 
of Exposure 
(days/year) 
Exposure 
Duration 
(years) 
Averaging time 
for 
Carcinogenic 
Substances: 
BDCM,  
DBCM, 
Bromoform 
 (Life time 70 
year x 
365days/year) 
Averaging time for 
Non-Carcinogenic 
Substances: 
Choloform 
(Exposure 
Duration year x 
365days/year) 
Exposure 
Factor - For 
Carcinogenic 
Substances 
Exposure 
Factor- For 
Non-
Carcinogenic 
Substances 
Smallest 
Exposure 
Scenario 365 70 25550 25550 1 1 
Lower 
Bond 
Scenario 
(%5) 365 70 25550 25550 1 1 
Central 
Tendency
(%50) 365 70 25550 25550 1 1 
Upper 
Bond 
Scenario 
(%95) 365 70 25550 25550 1 1 
Max 
Exposure 
Scenario 365 70 25550 25550 1 1 
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5.2. Results of the Exposure Dose by Water Ingestion 
Exposure dose (chronic daily intake, CDI) was implemented on THMs 
component based, incorporating parameters for chemical concentrations in the water 
supply, intake rate and human physical characteristics.      
Calculated values of CDI are presented in Tables 5.2, 5.3, 5.4, and 5.5 for chloroform, 
BDCM, DBCM, and bromoform, respectively.  Considerations about the calculations 
are as follows. 
- Concentrations and intake rate of a compound is calculated by interpolation for 
different scenarios such as lower bound, central tendency. 
- Body weight is also calculated by interpolation. But a negative correlation exists 
between body weight and exposure dose. When the body weight increase, 
exposure dose decreases.   
 
Table 5.2. Ingestion Dose for Chloroform 
 
 
Concentration of 
chloroform 
(mg/l) 
Intake rate 
(L/day) 
Exposure Factor- 
For non-
carcinogenic 
substances 
Body 
Weight 
(kg) 
Ingestion Dose For 
non-carcinogenic 
substances  
(mg /kg/day) 
Minimum Exposure 
Scenario 3.84×10-14 0.3666 1 96 1.47×10-16 
Lower Bound 
Exposure Scenario  8.10×10-11 0.40368 1 92.4 3.54×10-13 
Central Tendency 
Exposure Scenario 9.00×10-5 1.4284 1 67 1.92×10-6 
Upper Bound 
Exposure Scenario 2.99×10-2 3.11992 1 47,6 1.96×10-3 
Maximum Exposure 
Scenario 3.46×10-2 4.4856 1 47 3.30×10-3 
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Table 5.3. Ingestion Dose for Bromodichloromethane 
 
 
Concentration of 
BDCM (mg/l) 
Intake rate 
(L/day) 
Exposure Factor- 
For non-
carcinogenic 
substances 
Body 
Weight 
(kg) 
Ingestion Dose For 
carcinogenic 
substances  
(mg /kg/day ) 
Minimum Exposure 
Scenario 4.76×10-9 0.3666 1 96 1.82×10-11 
Lower Bound 
Exposure Scenario  7.40×10-7 0.40368 1 92.4 3.23×10-9 
Central Tendency 
Exposure Scenario 1.20×10-4 1.4284 1 67 2.56×10-6 
Upper Bound 
Exposure Scenario 2.46×10-2 3.11992 1 47.6 1.61×10-3 
Maximum Exposure 
Scenario 2.75×10-2 4.4856 1 47 2.62×10-3 
 
 
Table 5.4. Ingestion Dose for Dibromochloromethane 
 
 
Concentration of 
DBCM (mg/l) 
Intake rate 
(L/day) 
Exposure Factor- 
For non-
carcinogenic 
substances 
Body 
Weight 
(kg) 
Ingestion Dose For 
carcinogenic 
substances  
(mg /kg/day) 
Minimum Exposure 
Scenario 3.24×10-7 0.3666 1 96 1.24×10-9 
Lower Bound 
Exposure Scenario  7.03×10-7 0.40368 1 92.4 3.07×10-9 
Central Tendency 
Exposure Scenario 4.10×10-4 1.4284 1 67 8.74×10-6 
Upper Bound 
Exposure Scenario 1.53×10-2 3.11992 1 47.6 1.00×10-3 
Maximum Exposure 
Scenario 1.72×10-2 4.4856 1 47 1.64×10-3 
 
 
Table 5.5. Ingestion Dose for Bromoform 
 
 
Concentration of 
bromoform 
(mg/l) 
Intake rate 
(L/day) 
Exposure Factor- 
For non-
carcinogenic 
substances 
Body 
Weight 
(kg) 
Ingestion Dose For 
carcinogenic 
substances  
(mg /kg/day) 
Minimum Exposure 
Scenario 3.97×10-6 0.3666 1 96 1.52×10-8 
Lower Bound 
Exposure Scenario  1.40×10-5 0.40368 1 92.4 6.12×10-8 
Central Tendency 
Exposure Scenario 4.50×10-4 1.4284 1 67 9.59×10-6 
Upper Bound 
Exposure Scenario 2.52×10-3 3.11992 1 47.6 1.65×10-4 
Maximum Exposure 
Scenario 3.22×10-3 4.4856 1 47 3.07×10-4 
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5.3. Results of the Exposure Dose by Air Inhalation  
On the inhalation pathway, to determine the exposure dose, the effects of parameters 
are important. The results indicate that the pathway dose factor is most sensitive to 
changes in the uptake fraction in the lung, the ratio of breathing rate to body weight, the 
water to air transfer efficiency and the quantity of water used in showers. The exposure 
dose results are based on THMs component such as chloroform, 
dibromochloromethane, bromodichloromethane and bromoform.  Considerations about 
the calculations are as follows. 
- Air intake rate is different for men and women. 11.3 m3/day female 19-65 years; 
15.2 m
3
/day male 19-65 years (USEPA 1997). While establishing the scenarios, 
age and gender parameter is considered for the calculation of air intake rate. 
Intake rate of a compound is calculated by interpolation for different scenarios 
such as lower bound, central tendency. 
- Body weight is also calculated by interpolation. But a negative correlation exists 
between body weight and exposure dose. When the body weight increase, 
exposure dose decreases. 
- Transfer efficiency is an important factor to calculate the THMs concentrations 
from water to air. Assumed temperature values for different exposure related 
activities are given in Table 5.6.  Calculated transfer efficiencies follow in Table 
5.7. 
 
Table 5.6. Estimated Temperature for Activities  
(Source: Wilkes et al., 2002) 
 
Activity Temperature ˚C 
Showering    40 
Bathing and Dish Washing 35 
Hand washing 25 
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Table 5.7. Calculated Transfer Efficiencies 
 
Appliance Transfer Efficiency (Unitless) 
BDCM DBCM Bromoform 
Showering 0.4116 0.1716 0.1063 
Bathing 0.3961 0.1682 0.0988 
Hand wash 0.3808 0.1582 0.0884 
Dish wash 0.3961 0.1682 0.0988 
 
- THMs concentrations in air were calculated with the following equation. 
 
CTHM= (CChemical x RWater x Φ i 
j
 x ET) / RAir    (5.1) 
 
where, 
 
CTHM = THMs concentrations in air (g/m
3
) 
CChemical = Concentration of a chemical in water (g/L) 
RWater = Water use rate during the activity (L/h) 
Φ i 
j 
= Transfer efficiency from water to air (unitless) 
ET = Exposure time (min/day) 
RAir = Air exchange rate during the activity (m
3
/h) 
 
- Aggregate exposure for hand washing, shower, bath, dish washing activities was 
considered.  Calculated CDI values are presented in Tables 5.8, 5.9, 5.10, and 
5.11 for chloroform, BDCM, DBCM, and bromoform, respectively.   
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Table 5.8. Inhalation Dose for Chloroform 
 
 
Concentration of 
chloroform 
(mg/m
3
) 
Inhalation 
rate 
(m
3
/day) 
Exposure Factor- 
For non-
carcinogenic 
substances 
Body 
Weight 
(kg) 
Inhalation Dose 
For non-
carcinogenic 
substances  
(mg /kg/day) 
Minimum Exposure 
Scenario 4.88×10-15 11.3 1 96 5.75×10-16 
Lower Bound 
Exposure Scenario  1.74×10-11 11.3 1 92.4 2.13×10-12 
Central Tendency 
Exposure Scenario 4.74×10-4 11.3 1 67 7.99×10-5 
Upper Bound 
Exposure Scenario 3.35×10-1 15.2 1 47.6 1.07×10-1 
Maximum Exposure 
Scenario 5.17×10-1 15.2 1 47 1.67×10-1 
 
 
Table 5.9. Inhalation Dose for Bromodichloromethane 
 
 
Concentration of 
BDCM (mg/m
3
) 
Inhalation 
rate 
(m
3
/day) 
Exposure Factor- 
For carcinogenic 
substances 
Body 
Weight 
(kg) 
Inhalation Dose 
For carcinogenic 
substances  
(mg /kg/day) 
Minimum Exposure 
Scenario 5.95×10-10 11.3 1 96 7.00×10-11 
Lower Bound 
Exposure Scenario  1.37×10-7 11.3 1 92.4 1.67×10-8 
Central Tendency 
Exposure Scenario 5.17×10-4 11.3 1 67 8.72×10-5 
Upper Bound 
Exposure Scenario 1.44×10-1 15.2 1 47.6 4.59×10-2 
Maximum Exposure 
Scenario 2.58×10-1 15.2 1 47 8.35×10-2 
 
 
Table 5.10. Inhalation Dose for Dibromochloromethane 
 
 
Concentration of 
DBCM (mg/m
3
) 
Inhalation 
rate 
(m
3
/day) 
Exposure Factor- 
For carcinogenic 
substances 
Body 
Weight 
(kg) 
Inhalation Dose 
For carcinogenic 
substances  
(mg /kg/day) 
Minimum Exposure 
Scenario 2.39×10-8 11.3 1 96 2.82×10-9 
Lower Bound 
Exposure Scenario  4.13×10-7 11.3 1 92.4 5.05×10-8 
Central Tendency 
Exposure Scenario 8.97×10-4 11.3 1 67 1.51×10-4 
Upper Bound 
Exposure Scenario 4.04×10-2 15.2 1 47.6 1.29×10-2 
Maximum Exposure 
Scenario 6.80×10-2 15.2 1 47 2.20×10-2 
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Table 5.11. Inhalation Dose for Bromoform 
 
 
Concentration of 
bromoform 
(mg/m
3
) 
Inhalation 
rate 
(m
3
/day) 
Exposure Factor- 
For carcinogenic 
substances 
Body 
Weight 
(kg) 
Inhalation Dose 
For carcinogenic 
substances  
(mg /kg/day) 
Minimum Exposure 
Scenario 1.64×10-7 11.3 1 96 1.93×10-8 
Lower Bound 
Exposure Scenario  3.14×10-6 11.3 1 92.4 3.84×10-7 
Central Tendency 
Exposure Scenario 6.48×10-4 11.3 1 67 1.09×10-4 
Upper Bound 
Exposure Scenario 4.28×10-3 15.2 1 47.6 1.37×10-3 
Maximum Exposure 
Scenario 5.83×10-3 15.2 1 47 1.89×10-3 
 
5.4. Results of the Exposure Dose by Water Dermal Contact  
The parameters which affect dermal absorption dose are concentration of chemical, 
permeability coefficient, surface area dermal intake contact, exposure time, and body 
weight. Permeability coefficient values were obtained from the literature and presented 
in Table 5.12. Calculated values of CDI are presented in Tables 5.13 to 5.20.  
Considerations about the calculations are as follows. 
Dermal exposure calculations are divided into two groups because of different 
body surface area depends on activity type. Bath and showering is the first group. Body 
surface area is classified as the whole body area. The second group is hand and dish 
washing. Body surface area is classified as hand area.  
- Exposure time and concentration are calculated for the first group and the 
second group separately by interpolation for different scenarios such as lower 
bound, central tendency. 
- Body weight is also calculated by interpolation. But a negative correlation exists 
between body weight and exposure dose. When the body weight increase, 
exposure dose decreases. 
- Body surface area is calculated according to equation (4.6) . Surface area in cm2 
for hands is %4 of total body surface area (Edward et al., 2001). 
- Permeability coefficient, for the outermost layer of the skin, is a measure of a 
contaminant’s capacity to permeate through it. In dermal exposure permeability 
coefficient, in cm/hr, depends on type of chemical. 
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Table 5.12. Permeability Coefficients (Kps) For Some Chemicals  
(Source: US EPA, 2003) 
 
Chemical Name Kp(cm/hr) 
Chloroform 8.90×10-3 
Bromoform 2.60×10-3 
Bromodichloromethane 5.80×10-3 
Chlorodibromomethane 3.90×10-3 
 
 
Table 5.13. Dermal Dose for Chloroform During Bath and Shower 
 
 
Concentration 
of chloroform 
(mg/l) 
Permeability 
coefficient 
(cm/hr) 
Exposed 
body 
surface 
area (cm
2
) 
Exposure 
Time 
(h/day) 
Conversion 
Factor  (1L/ 
1000cm
3
) 
Body 
Weight 
(kg) 
Dermal Dose 
For non-
carcinogenic 
substances  
(mg 
/kg/day) 
Minimum 
Exposure 
Scenario 3.84×10-14 0.0089 14141 1.83×10-1 0.001 96 9.23×10-18 
Lower Bound 
Exposure 
Scenario  8.10×10-11 0.0089 14257 1.83×10-1 0.001 92.4 2.04×10-14 
Central 
Tendency 
Exposure 
Scenario 9.00×10-5 0.0089 17784 4.45×10-1 0.001 67 9.45×10-8 
Upper Bound 
Exposure 
Scenario 2.99×10-2 0.0089 21893 1.23 0.001 47.6 1.51×10-4 
Maximum 
Exposure 
Scenario 3.46×10-2 0.0089 22441 2.33 0.001 47 3.43×10-4 
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Table 5.14. Dermal Dose for Bromodichloromethane During Bath and Shower 
 
 
Concentration 
of BDCM 
(mg/l) 
Permeability 
coefficient 
(cm/hr) 
Exposed 
body 
surface 
area (cm
2
) 
Exposure 
Time 
(h/day) 
Conversion 
Factor  (1L/ 
1000cm
3
) 
Body 
Weight 
(kg) 
Dermal Dose 
For 
carcinogenic 
substances  
(mg 
/kg/day) 
Minimum 
Exposure 
Scenario 4.76×10-9 0.0058 14141 1.83×10-1 0.001 96 7.46×10-13 
Lower Bound 
Exposure 
Scenario  7.40×10-7 0.0058 14257 1.83×10-1 0.001 92.4 1.21×10-10 
Central 
Tendency 
Exposure 
Scenario 1.20×10-4 0.0058 17784 4.45×10-1 0.001 67 8.21×10-8 
Upper Bound 
Exposure 
Scenario 2.46×10-2 0.0058 21893 1.23 0.001 47.6 8.09×10-5 
Maximum 
Exposure 
Scenario 2.75×10-2 0.0058 22441 2.33 0.001 47 1.78×10-4 
 
 
Table 5.15. Dermal Dose for Dibromochloromethane During Bath and Shower 
 
 
Concentration 
of DBCM 
(mg/l) 
Permeability 
coefficient 
(cm/hr) 
Exposed 
body 
surface 
area (cm
2
) 
Exposure 
Time 
(h/day) 
Conversion 
Factor  (1L/ 
1000cm
3
) 
Body 
Weight 
(kg) 
Dermal Dose 
For 
carcinogenic 
substances  
(mg 
/kg/day) 
Minimum 
Exposure 
Scenario 3.24×10-7 0.0039 14141 1.83×10-1 0.001 96 3.41×10-11 
Lower Bound 
Exposure 
Scenario  7.03×10-7 0.0039 14257 1.83×10-1 0.001 92.4 7.76×10-11 
Central 
Tendency 
Exposure 
Scenario 4.10×10-4 0.0039 17784 4.45×10-1 0.001 67 189×10-7 
Upper Bound 
Exposure 
Scenario 1.53×10-2 0.0039 21893 1.23 0.001 47.6 3.38×10-5 
Maximum 
Exposure 
Scenario 1.72×10-2 0.0039 22441 2.33 0.001 47 7.47×10-5 
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Table 5.16. Dermal Dose for Bromoform During Bath and Shower 
 
 
Concentration 
of bromoform 
(mg/l) 
Permeability 
coefficient 
(cm/hr) 
Exposed 
body 
surface 
area (cm
2
) 
Exposure 
Time 
(h/day) 
Conversion 
Factor  (1L/ 
1000cm
3
) 
Body 
Weight 
(kg) 
Dermal Dose 
For 
carcinogenic 
substances  
(mg 
/kg/day) 
Minimum 
Exposure 
Scenario 3.97×10-6 0.0026 14141 1.83×10-1 0.001 96 2.79×10-10 
Lower Bound 
Exposure 
Scenario  1.40×10-5 0.0026 14257 1.83×10-1 0.001 92.4 1.03×10-9 
Central 
Tendency 
Exposure 
Scenario 4.50×10-4 0.0026 17784 4.45×10-1 0.001 67 1.38×10-7 
Upper Bound 
Exposure 
Scenario 2.52×10-3 0.0026 21893 1.23 0.001 47.6 3.71×10-6 
Maximum 
Exposure 
Scenario 3.22×10-3 0.0026 22441 2.33 0.001 47 9.33×10-6 
 
 
 Table 5.17. Dermal Dose for Chloroform During Dish and Hand Wash 
 
 
Concentration 
of chloroform 
(mg/l) 
Permeability 
coefficient 
(cm/hr) 
Exposed 
body 
surface 
area (cm
2
) 
Exposure 
Time 
(h/day) 
Conversion 
Factor  (1L/ 
1000cm
3
) 
Body 
Weight 
(kg) 
Dermal Dose 
For non-
carcinogenic 
substances  
(mg 
/kg/day) 
Minimum 
Exposure 
Scenario 3.84×10-14 0.0089 14141 1.83×10-1 0.001 96 1.49×10-19 
Lower Bound 
Exposure 
Scenario  8.10×10-11 0.0089 14257 1.83×10-1 0.001 92.4 4.24×10-16 
Central 
Tendency 
Exposure 
Scenario 9.00×10-5 0.0089 17784 4.45×10-1 0.001 67 4.14×10-9 
Upper Bound 
Exposure 
Scenario 2.99×10-2 0.0089 21893 1.23 0.001 47.6 5.61×10-6 
Maximum 
Exposure 
Scenario 3.46×10-2 0.0089 22441 2.33 0.001 47 3.33×10-5 
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 Table 5.18. Dermal Dose for Bromodichloromethane During Dish and Hand  
              Wash 
 
 
Concentration 
of BDCM 
(mg/l) 
Permeability 
coefficient 
(cm/hr) 
Exposed 
body 
surface 
area (cm
2
) 
Exposure 
Time 
(h/day) 
Conversion 
Factor  (1L/ 
1000cm
3
) 
Body 
Weight 
(kg) 
Dermal Dose 
For 
carcinogenic 
substances  
(mg 
/kg/day) 
Minimum 
Exposure 
Scenario 4.76×10-9 0.0058 14141 1.83×10-1 0.001 96 1.20×10-14 
Lower Bound 
Exposure 
Scenario  7.40×10-7 0.0058 14257 1.83×10-1 0.001 92.4 2.52×10-12 
Central 
Tendency 
Exposure 
Scenario 1.20×10-4 0.0058 17784 4.45×10-1 0.001 67 3.60×10-9 
Upper Bound 
Exposure 
Scenario 2.46×10-2 0.0058 21893 1.23 0.001 47.6 3.01×10-6 
Maximum 
Exposure 
Scenario 2.75×10-2 0.0058 22441 2.33 0.001 47 1.72×10-5 
 
 
 Table 5.19. Dermal Dose for Dibromochloromethane During Dish and Hand  
              Wash 
 
 
Concentration 
of DBCM 
(mg/l) 
Permeability 
coefficient 
(cm/hr) 
Exposed 
body 
surface 
area (cm
2
) 
Exposure 
Time 
(h/day) 
Conversion 
Factor  (1L/ 
1000cm
3
) 
Body 
Weight 
(kg) 
Dermal Dose 
For 
carcinogenic 
substances  
(mg 
/kg/day) 
Minimum 
Exposure 
Scenario 3.24×10-7 0.0039 14141 1.83×10-1 0.001 96 5.49×10-13 
Lower Bound 
Exposure 
Scenario  7.03×10-7 0.0039 14257 1.83×10-1 0.001 92.4 1.61×10-12 
Central 
Tendency 
Exposure 
Scenario 4.10×10-4 0.0039 17784 4.45×10-1 0.001 67 8.27×10-9 
Upper Bound 
Exposure 
Scenario 1.53×10-2 0.0039 21893 1.23 0.001 47.6 1.26×10-6 
Maximum 
Exposure 
Scenario 1.72×10-2 0.0039 22441 2.33 0.001 47 7.24×10-6 
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 Table 5.20. Dermal Dose for Bromoform During Dish and Hand Wash 
 
 
Concentration 
of bromoform 
(mg/l) 
Permeability 
coefficient 
(cm/hr) 
Exposed 
body 
surface 
area (cm
2
) 
Exposure 
Time 
(h/day) 
Conversion 
Factor  (1L/ 
1000cm
3
) 
Body 
Weight 
(kg) 
Dermal Dose 
For 
carcinogenic 
substances  
(mg 
/kg/day) 
Minimum 
Exposure 
Scenario 3.97×10-6 0.0026 14141 1.83×10-1 0.001 96 4.49×10-12 
Lower Bound 
Exposure 
Scenario  1.40×10-5 0.0026 14257 1.83×10-1 0.001 92.4 2.14×10-11 
Central 
Tendency 
Exposure 
Scenario 4.50×10-4 0.0026 17784 4.45×10-1 0.001 67 6.05×10-9 
Upper Bound 
Exposure 
Scenario 2.52×10-3 0.0026 21893 1.23 0.001 47.6 1.38×10-7 
Maximum 
Exposure 
Scenario 3.22×10-3 0.0026 22441 2.33 0.001 47 9.04×10-7 
  
5.5. Risk Results for Water Ingestion 
Quantifying the risk is important for population and decision making policy for 
drinking water safety. The human risk assessment was conducted to evaluate 
carcinogenic risk from exposure to THMs in drinking water. The following tables 
present the estimated risk levels associated with ingestion of THMs in drinking water. 
Choloroform was considered as noncarcinogenic and carcinogenic substance. 
Therefore, both hazard quotient and risk calculated. Carcinogenic risk of choloroform 
for ingestion is calculated by using slope factor as 6.1×10-3 (RAIS, 2009). For 
bromodichloromethane, dibromochloromethane and bromoform, the risk was 
implemented by two different methods as simple addition and ICED. 
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Table 5.21. Ingestion Risk for Chloroform 
 
 
Chronic-Toxic Risk  
Hazard Quotient Carcinogenic Risk  
Minimum Exposure Scenario 1.47×10-14 8.95×10-19 
Lower Bound Exposure 
Scenario  3.54×10-11 2.16×10-15 
Central Tendency Exposure 
Scenario 1.92×10-4 1.17×10-8 
Upper Bound Exposure 
Scenario 1.96×10-1 1.20×10-5 
Maximum Exposure Scenario 3.30×10-1 2.01×10-5 
 
 
Table 5.22. Ingestion Risk for Bromodichloromethane 
 
 Carcinogenic Risk  RPF= SF BDCM/SF BDCM 
Component ICED 
for BDCM 
Minimum Exposure Scenario 1.13×10-12 1.00 1.82×10-11 
Lower Bound Exposure 
Scenario  2.00×10-10 1.00 3.23×10-9 
Central Tendency Exposure 
Scenario 1.59×10-7 1.00 2.56×10-6 
Upper Bound Exposure 
Scenario 1.00×10-4 1.00 1.61×10-3 
Maximum Exposure Scenario 1.63×10-4 1.00 2.62×10-3 
 
 
Table 5.23. Ingestion Risk for Dibromochloromethane 
 
 Carcinogenic Risk RPF= SF DBCM/SF BDCM 
Component ICED 
for DBCM 
Minimum Exposure Scenario 1.04×10-10 1.354839 1.68×10-9 
Lower Bound Exposure 
Scenario  2.58×10-10 1.354839 4.16×10-9 
Central Tendency Exposure 
Scenario 7.34×10-7 1.354839 1.18×10-5 
Upper Bound Exposure 
Scenario 8.42×10-5 1.354839 1.36×10-3 
Maximum Exposure Scenario 1.38×10-4 1.354839 2.22×10-3 
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Table 5.24. Ingestion Risk for Bromoform 
 
 Carcinogenic Risk RPF= SF CHBr3/SF BDCM 
Component ICED 
for Bromoform 
Minimum Exposure Scenario 1.19767×10-10 0.127419 1.93×10-9 
Lower Bound Exposure 
Scenario  4.83469×10-10 0.127419 7.80×10-9 
Central Tendency Exposure 
Scenario 7.57905×10-8 0.127419 1.22×10-6 
Upper Bound Exposure 
Scenario 1.30279×10-6 0.127419 2.10×10-5 
Maximum Exposure Scenario 2.42776×10-6 0.127419 3.91×10-5 
 
5.6. Risk Results for Air Inhalation 
Inhalation risk values were estimated by THM exposures in showering, bathing, 
and dish and hand washing. Risk values, by two different methods, for carcinogenic 
THMs species are present in below tables. For chloroform, hazard quotient and risk are 
available. Carcinogenic risk of choloroform for inhalation is calculated by using slope 
factor as 8.1×10-2 (RAIS, 2009). 
 
Table 5.25. Inhalation Risk for Chloroform 
 
 
Hazard Quotient 
For Non-Carcinogenic Substances Risk For Carcinogenic Substances 
Minimum Exposure Scenario 5.75×10-14 4.65×10-17 
Lower Bound Exposure 
Scenario  2.13×10-10 1.72×10-13 
Central Tendency Exposure 
Scenario 7.99×10-3 6.47×10-6 
Upper Bound Exposure 
Scenario 1.07×101 8.68×10-3 
Maximum Exposure Scenario 1.67×101 1.35×10-2 
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Table 5.26. Inhalation Risk for Bromodichloromethane 
 
 Carcinogenic Risk RPF= SF BDCM/SF BDCM 
Component ICED 
for BDCM 
Minimum Exposure Scenario 4.34×10-12 1.00 7.00×10-11 
Lower Bound Exposure 
Scenario  1.04×10-9 
1.00 
1.67×10-8 
Central Tendency Exposure 
Scenario 5.40×10-6 
1.00 
8.72×10-5 
Upper Bound Exposure 
Scenario 2.85×10-3 
1.00 
4.59×10-2 
Maximum Exposure Scenario 5.18×10-3 1.00 8.35×10-2 
 
 
Table 5.27. Inhalation Risk for Dibromochloromethane 
 
 Carcinogenic Risk RPF= SF DBCM/SF BDCM 
Component ICED for 
DBCM 
Minimum Exposure 
Scenario 2.37×10-10 1.354839 3.82×10-9 
Lower Bound Exposure 
Scenario  4.24×10-9 1.354839 6.84×10-8 
Central Tendency Exposure 
Scenario 1.27×10-5 1.354839 2.05×10-4 
Upper Bound Exposure 
Scenario 1.08×10-3 1.354839 1.75×10-2 
Maximum Exposure 
Scenario 1.85×10-3 1.354839 2.98×10-2 
 
 
Table 5.28. Inhalation Risk for Bromoform 
 
 Carcinogenic Risk RPF= SF CHBr3/SF BDCM 
Component ICED for 
Bromoform 
Minimum Exposure 
Scenario 1.52×10-10 0.127419 2.46×10-9 
Lower Bound Exposure 
Scenario  3.03×10-9 0.127419 4.89×10-8 
Central Tendency Exposure 
Scenario 8.64×10-7 0.127419 1.39×10-5 
Upper Bound Exposure 
Scenario 1.08×10-5 0.127419 1.74×10-4 
Maximum Exposure 
Scenario 1.49x10
-5
 0.127419 2.40x10
-4
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5.7. Risk Results for Water Dermal Contact  
Dermal risk estimation divided into two groups because of different activities and 
exposure doses. One group risk is result of bathing and showering activities; the other 
group is hand and dish washing. Carcinogenic and noncarcinogenic risks were 
associated with the species of THMs. For chloroform, hazard quotient and risk are 
available. Carcinogenic risk of choloroform for dermal route is calculated by using 
slope factor as 6.1×10-3 (Lee et al., 2009). 
Tables 5.29-5.32 present dermal absorption risks associated with bathing and 
showering activities, Tables 5.33-5.36 present dermal absorption risks associated with 
hand and dish washing. 
 
Table 5.29. Bathing and Showering Dermal Risk for Chloroform 
 
 
Hazard Quotient 
For Non-Carcinogenic Substances 
Risk For Carcinogenic 
Substances??? 
Minimum Exposure Scenario 9.23×10-16 5.63×10-20 
Lower Bound Exposure 
Scenario  2.04×10-12 1.24×10-16 
Central Tendency Exposure 
Scenario 9.45×10-6 5.76×10-10 
Upper Bound Exposure 
Scenario 1.51×10-2 9.21×10-7 
Maximum Exposure Scenario 3.43×10-2 2.09×10-6 
 
 
Table 5.30. Bathing and Showering Dermal Risk for Bromodichloromethane 
 
 Carcinogenic Risk RPF= SF BDCM/SF BDCM 
Component ICED 
for BDCM 
Minimum Exposure Scenario 4.62×10-14 1.000000 7.46×10-13 
Lower Bound Exposure 
Scenario  7.53×10-12 1.000000 1.21×10-10 
Central Tendency Exposure 
Scenario 5.09×10-9 1.000000 8.21×10-8 
Upper Bound Exposure 
Scenario 5.02×10-6 1.000000 8.09×10-5 
Maximum Exposure Scenario 1.10×10-5 1.000000 1.78×10-4 
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Table 5.31. Bathing and Showering Dermal Risk for Dibromochloromethane 
 
 Carcinogenic Risk RPF= SF DBCM/SF BDCM 
Component ICED for 
DBCM 
Minimum Exposure 
Scenario 2.87×10-12 1.354839 4.62×10-11 
Lower Bound Exposure 
Scenario  6.52×10-12 1.354839 1.05×10-10 
Central Tendency Exposure 
Scenario 1.58×10-8 1.354839 2.56×10-7 
Upper Bound Exposure 
Scenario 2.84×10-6 1.354839 4.59×10-5 
Maximum Exposure 
Scenario 6.28×10-6 1.354839 1.01×10-4 
 
 
Table 5.32. Bathing and Showering Dermal Risk for Bromoform 
 
 Carcinogenic Risk RPF= SF CHBr3/SF BDCM 
Component ICED for 
Bromoform 
Minimum Exposure 
Scenario 2.20×10-12 0.127419 3.55×10-11 
Lower Bound Exposure 
Scenario  8.14×10-12 0.127419 1.31×10-10 
Central Tendency Exposure 
Scenario 1.09×10-9 0.127419 1.76×10-8 
Upper Bound Exposure 
Scenario 2.93×10-8 0.127419 4.73×10-7 
Maximum Exposure 
Scenario 7.37×10-8 0.127419 1.19×10-6 
 
 
Table 5.33. Dish and Hand Washing Dermal Risk for Chloroform 
 
 
Hazard Quotient 
For Non-Carcinogenic Substances Risk For Carcinogenic Substances 
Minimum Exposure Scenario 1.49×10-17 9.07×10-22 
Lower Bound Exposure 
Scenario  4.24×10-14 2.59×10-18 
Central Tendency Exposure 
Scenario 4.14×10-7 2.53×10-11 
Upper Bound Exposure 
Scenario 5.61×10-4 3.43×10-8 
Maximum Exposure Scenario 3.33×10-3 2.03×10-7 
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Table 5.34. Dish and Hand Washing Dermal Risk for Bromodichloromethane 
 
 Carcinogenic Risk RPF= SF BDCM/SF BDCM 
Component ICED 
for BDCM 
Minimum Exposure Scenario 7.44×10-16 1.00 1.20×10-14 
Lower Bound Exposure 
Scenario  1.56×10-13 1.00 2.52×10-12 
Central Tendency Exposure 
Scenario 2.23×10-10 1.00 3.60×10-9 
Upper Bound Exposure 
Scenario 1.87×10-7 1.00 3.01×10-6 
Maximum Exposure Scenario 1.07×10-6 1.00 1.72×10-5 
 
 
Table 5.35. Dish and Hand Washing Dermal Risk for Dibromochloromethane 
 
 Carcinogenic Risk RFD= SF DBCM/SF BDCM 
Component ICED for 
DBCM 
Minimum Exposure 
Scenario 4.62×10-14 1.354839 7.44×10-13 
Lower Bound Exposure 
Scenario  1.35×10-13 1.354839 2.18×10-12 
Central Tendency Exposure 
Scenario 6.94×10-10 1.354839 1.12×10-8 
Upper Bound Exposure 
Scenario 1.06×10-7 1.354839 1.71×10-6 
Maximum Exposure 
Scenario 6.09×10-7 1.354839 9.82×10-6 
 
 
Table 5.36. Dish and Hand Washing Dermal Risk for Bromoform 
 
 Carcinogenic Risk RPF= SF CHBr3/SF BDCM 
Component ICED for 
Bromoform 
Minimum Exposure 
Scenario 3.55×10-14 0.127419 5.71901×10-13 
Lower Bound Exposure 
Scenario  1.69×10-13 0.127419 2.72763×10-12 
Central Tendency Exposure 
Scenario 4.78×10-11 0.127419 7.70698×10-10 
Upper Bound Exposure 
Scenario 1.09×10-9 0.127419 1.75872×10-8 
Maximum Exposure 
Scenario 7.14×10-9 0.127419 1.15206×10-7 
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5.8. Total Risk 
We estimated the multi-pathway exposure risk assessment based on the 
concentrations of THMs measured in water. Cancer risk caused by exposure through 
oral ingestion, dermal absorption and inhalation were considered in this study. 
Cumulative risk was calculated over one route of exposure for the four THMs. 
Chloroform was contributed to total risk by summing the carcinogenic risk of all the 
routes. Cumulative risks were brought together to estimate the total risk. Cumulative 
and total risks are calculated by two methods which are additive method and ICED 
method.  
In ICED approach, MLE slope factors are from the same dose−response model 
as the 95% upper bound slope factors. Genotoxic subclass index chemical, maximum 
likelihood estimate (MLE) of cancer slope factor (SF) =5.7×10-3 (Teuschler, 2004).  
Tables 5.37 to 5.39 present the cumulative risks for the three exposure routes.  Table 40 
follows with the estimated total risk values. 
 
Table 5.37. Cumulative Risk for Ingestion Route 
 
 ADDITIVE METHOD ICED METHOD 
 
Total Carcinogenic Risk  
 
Subclass ICED 
(mg/kg/d) 
Subclass Risk=MLE 
Slope Factor × Subclass 
ICED  
Minimum Exposure Scenario 2.25×10-10 3.63×10-9 2.07×10-11 
Lower Bound Exposure 
Scenario  9.42×10-10 1.52×10-8 8.66×10-11 
Central Tendency Exposure 
Scenario 9.69×10-7 1.56×10-5 8.91×10-8 
Upper Bound Exposure 
Scenario 1.86×10-4 2.99×10-3 1.71×10-5 
Maximum Exposure Scenario 3.03×10-4 4.89×10-3 2.79×10-5 
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Table 5.38. Cumulative Risk for Inhalation Route 
 
 ADDITIVE METHOD ICED METHOD 
 Total Carcinogenic Risk 
Subclass ICED  
(mg/kg/d) 
Subclass Risk=MLE 
Slope Factor × Subclass 
ICED  
Minimum Exposure Scenario 3.93×10-10 6.34×10-9 3.62×10-11 
Lower Bound Exposure 
Scenario  8.31×10-9 1.34×10-7 7.64×10-10 
Central Tendency Exposure 
Scenario 1.90×10-5 3.06×10-4 1.75×10-6 
Upper Bound Exposure 
Scenario 3.94×10-3 6.36×10-2 3.62×10-4 
Maximum Exposure Scenario 7.04×10-3 1.14×10-1 6.47×10-4 
 
 
Table 5.39. Cumulative Risk for Dermal Route 
 
 ADDITIVE METHOD ICED METHOD 
 Total Carcinogenic Risk 
Subclass ICED 
(mg/kg/d) 
Subclass Risk=MLE 
Slope Factor × Subclass 
ICED  
Minimum Exposure Scenario 5.20×10-12 8.38×10-11 4.78×10-13 
Lower Bound Exposure 
Scenario  2.26×10-11 3.65×10-10 2.08×10-12 
Central Tendency Exposure 
Scenario 2.30×10-8 3.71×10-7 2.11×10-9 
Upper Bound Exposure 
Scenario 8.18×10-6 1.32×10-4 7.52×10-7 
Maximum Exposure Scenario 1.91×10-5 3.07×10-4 1.75×10-6 
 
 
Table 5.40. Estimated Total Carcinogenic Risk  
 
 ADDITIVE METHOD ICED METHOD 
 Total Carcinogenic Risk 
Subclass Risk=MLE Slope Factor × 
Subclass ICED  
Minimum Exposure Scenario 6.23×10-10 5.73×10-11 
Lower Bound Exposure 
Scenario  9.28×10-9 8.53×10-10 
Central Tendency Exposure 
Scenario 2.00×10-5 1.84×10-6 
Upper Bound Exposure 
Scenario 4.14×10-3 3.80×10-4 
Maximum Exposure Scenario 7.36×10-3 6.77×10-4 
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CHAPTER 6 
DISCUSSION 
Estimation of cumulative or total human health risks associated with different 
compounds in a mixture is subject of debate. The cumulative or total risks have been 
estimated by simply adding risks associated with each compound in the mixture (Legay 
et al., 2011; Lee et al., 2004; Tokmak et al., 2006; Uyak, 2005). However, the simple 
addition may result in overestimation of the risks. Therefore, a new cumulative / total 
risk assessment scheme has recently been proposed (Teuschler et al., 2004). This study 
estimated cumulative and total carcinogenic risks (by considering all three possible 
exposure routes) associated with trihalomethanes found in İzmir tap water both through 
simple addition and the proposed new scheme (Cumulative Relative Potency Factor, 
CRPF) and compared the resulting risk levels. 
The establishment of safety standards (maximum permissible contaminant 
levels) for chemicals in drinking water has generally, been based on the assumption that 
ingestion is the primary route for human exposure. However, recent research has shown 
that inhalation exposure, during water use activities like dish washing, showering and 
bathing, can have an equally significant, if not higher, impact on human exposure (Lee 
et al., 2009). Also, exposure due to dermal absorption of chemicals during dish and 
hand washing, showering, bathing have been shown to be comparable to direct 
ingestion of water. Villanueva et al. (2006) found that bladder cancer risk tended to be 
higher for exposure through showering, bathing and swimming in pools compared with 
drinking of water, but differences were small. Inhalation or dermal absorption may lead 
to a higher concentration directly in target organs (e.g., kidney, bladder, or colon), 
bypassing efficient detoxification steps in the liver that occur upon ingestion. The 
lowest contribution to the total cancer risk was due to dermal uptake (Tokmak et al., 
2004). We estimated the risks for four exposure scenarios: minimum, lower bound, 
central tendency, upper bound and maximum. In this study, central tendency scenario, 
cumulative risk for dermal route was 2.11×10-9 ; for inhalation route it was 1.75×10-6; 
and for ingestion route it was 8.91×10-8. Inhalation exposure had the most significant 
impact on human exposure; then ingestion, and then dermal exposure. Traditional risk 
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assessments of water often consider only ingestion exposure to toxic chemicals, but 
scientists proposed that inhalation and dermal absorption be considered in the risk 
assessment of drinking water Uyak (2005). Tokmak et al. (2004) and Lee et al. (2004) 
found that oral ingestion is the pathway most hazardous to human health in terms of 
cancer risk of THMs. On the other hand, Lee et al. (2006) conducted a study about risk 
assessment for THMs species in drinking water in Taiwan. In the exposure assessment 
calculation, inhalation was found as the principal pathway. The next pathway was 
ingestion followed by dermal intake.  
 One of the important factors in for inhalation exposure is transfer efficiency of 
THMs from water to air. There are several studies to estimate of chloroform levels in 
the air by using a volatilization factor (Legay et al., 2011; Uyak, 2005; Tokmak et al., 
2004). For instance, Legay et al. (2011) used the same volatilization factor for each 
THM compound to calculate the concentration of component in the air. Very few 
studies are available characterizing volatilization of chemicals during bathing / 
showering, and in washing machines and dishwashers. One of them is McKone’s (1987) 
model. According to McKone’s (1987) model transfer efficiency data for different 
compartments (shower, bathroom and the main house) has been calculated. Major 
factors that contribute to the volatilization of a contaminant were the water flow rate 
used, the temperature of the water, and the contaminant’s volatility, expressed by its 
Henry’s constant. 
Another important exposure pathway associated with tap water is the absorption 
of contaminants through the skin during water use activities. Primary activities resulting 
in skin contact with contaminated water are bathing and showering which have contact 
area as the whole body surface; secondary activities are dish and hand washing which 
have contact area as hand surface area.  In this study, the activities of showering, 
bathing and washing hands were considered for dermal exposure analysis. Chemical 
Specific Permeability Coefficient (Kps) for the outermost layer of the skin was used as a 
measure of a contaminant’s capacity to permeate through it. Lee et al. (2004) used a 
permeability of 0.0020m/h; but it was not chemical specific. Another study was 
conducted by Lévesque et al. (2000). As a result, overall water to skin permeability was 
reported to be 0.22 cm/h for each component. However, USEPA (1997)  recommends 
chemical specific permeation. We used Kps values recommended by the USEPA (2003) 
(see Table 5.12).   
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Risk assessment requires calculation of the chronic daily intake. Chronic daily 
intake (mg/kg/d) is the combination of water contaminant concentration (mg/L), 
average daily intake rate of drinking water (L/d) and the body weight (kg). In our study, 
we used measured values of these three input variables to estimate chronic daily 
exposure in each exposure scenario considered. However, there are some studies in the 
literature which used constant values for one or more of these variables. Lee el al. 
(2006) assumed an intake rate of 2,5 L/day. Tokmak et al. (2004), Uyak (2005) and 
Legay et al. (2011) also used constants for these variables. Therefore, the risk levels 
reported in these studies do not reflect the variation in the population in terms of these 
variables. 
In general, there are three broad sources of uncertainty: scenario uncertainty, 
model uncertainty and variable uncertainty. Scenario uncertainty involves the inferences 
selected for the exposure scenarios. Model uncertainty refers to the uncertainty due to 
the mathematical model used to estimate the exposure-risk or a dose-response 
relationship. Variable uncertainty refers to uncertainty for the values of the variables in 
the exposure or risk model (USEPA, 1997). In our study uncertainties were not 
calculated. The uncertainties may be studied as a future study. 
Probabilistic approach involves using probability distributions to represent each 
variable in exposure and risk equations. The range of values these are input variables 
and weight of these values by their probability of occurrence are concerned. In this 
study, instead of random sampling from input variable distributions to simulate the 
exposure-risk model probabilistically, we constructed five exposure scenarios: 
minimum, lower bound, central tendency, upper bound, and maximum. Minimum and 
maximum exposure scenarios considered the minimum and maximum values of each 
input variable that would minimize or maximize the model output (exposure-risk) value, 
while similarly 5
th
 and 95
th
 percentile values were used in lower and upper bound 
scenarios. The central tendency scenario used the median value of each input variable to 
calculate a 50
th
 percentile exposure-risk value. Therefore, exposure-risk values that may 
be considered as the estimations for İzmir population. As a future study, Monte-Carlo 
simulation may be employed to probabilistically estimate the population risks. This 
way, an uncertainty analysis can be conducted to estimate scenario and variable 
uncertainty.   
Total carcinogenic risk for drinking-water has been calculated as a measure of 
the probability of incurring a disease caused by THMs. The two methods for cumulative 
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/ total risk assessment (the simple addition and CRPF) were compared. CRPF method is 
a new method that combines the principles of dose addition and response addition into 
one method to assess mixture risks for multiple route exposures. Dose addition method 
groups contaminants with a common mode of action into subclasses. The mode of 
action differs across the subclasses, but the toxicological end point (or outcome) is the 
same. For each subclass, an index chemical is selected to be representative of that 
subclass. In this study, dose addition was applied but response addition was not applied 
because THMs are thought to have a similar toxicity mechanism for carcinogenic 
effects.  Dose addition is applied within each subclass. However, a toxicity normalized 
addition based on an index chemical approach was proposed instead of a simple 
addition. Here, the selection of the index chemical is an important step. The mixture 
component with the largest and most confident body of knowledge was proposed to be 
selected as the index chemical (Teuchler et al., 2004). Teuchler et al. (2004) used 
trihalomethanes as an exemplary application. They selected bromodichloromethane as 
the index chemical because it has the strength and complete toxicity data and the same 
mode of action as the other members of the subclass. Therefore, we also used it as the 
index chemical in this study. The total risk levels estimated by the simple addition 
method were an order of magnitude higher than those of by the CRPF method. This is a 
very large difference in terms of pollution/risk management, therefore a special 
attention should be paid to the method used to estimate cumulative or total carcinogenic 
risks for THMs. 
Presence of THMs was reported in many studies, whereas only a few studies 
estimated exposures and risks such as Legay et al. (2011) in Canada, Lee et al. (2004) in 
Hong Kong, Tokmak et al. (2004) in Ankara, Uyak (2005) in İstanbul. In all these 
studies, the cumulative / total risks estimated using the simple addition method. Among 
THMs, chloroform is the most frequently detected, generally the largest-concentration 
compound which indicates the presence of other DBPs. Legay et al. (2011) found that 
chloroform was the major by-product in the air to which people are exposed during 
showering and bathing activities, since it has a lower boiling point than the other three 
THMs. Concentration of chloroform in drinking water varied between 14.1 µg/L and 
155.9 µg/L in their study. There were two scenarios: cancer risk with chloroform and 
cancer risk without chloroform, because carcinogenity of chloroform at drinking water 
levels was considered as not appropriate by the USEPA (1997). Inclusion of chloroform 
seriously increases the carcinogenic risk for surface water source, chlorinated drinking 
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waters. In our study, we have not included chloroform as recommended by the USEPA 
(1997). At maximum exposure scenario, chloroform concentration of inhalation was 
517µg/L in our study, which (similar to what Legay et al. [2011] reported) resulted in a 
very high chronic toxic risk levels (HQ=16.7) for inhalation. We have considered 
volatilization of all THMs, while Legay et al. (2011) considered only chloroform.  
Lee et al. (2004) estimated chronic-toxic risks for ingestion and dermal 
absorption routes. The average total non-carcinogenic risk level (Hazard Index, 
HI=0.35) was below the threshold level of HI=1. In this study, HQ was calculated for 
chloroform for ingestion, inhalation, and dermal routes. The median HQ values were 
ranked from high to low as inhalation route (HQ=7.99×10-3), ingestion route 
(HQ=1.92×10-4) and dermal route (HQ=9.45×10-6 - 4.14×10-7). The lifetime total cancer 
risks calculated for total THMs were 2.00×10-5 with simple addition method and 
1.84×10-6 with CRPF method. Lee et al. (2004) reported an average carcinogenic risk 
value of 9.76×10-5 calculated by the simple addition method including chloroform. The 
risks observed by the additive method were generally in agreement with other literature 
values. Risk values greater than one in a million (10
-6
) are generally considered 
unacceptable by the USEPA (2000b). USEPA (2000b) have the flexibility to adopt 
water quality criteria that result in a risk level higher than 10
-6
, ensuring that highly 
exposed groups do not exceed a target 10
-4
 risk level. Four categories were identified for 
the unit cancer risk. RT < 10
-6
 No action is needed. 10
-6
<RT < 5.10
-5
 and 5.10
-5
<RT <10
-4 
represent generally acceptable levels of carcinogenic risk and the related zones are 
considered at low priority. RT > 10
-4 
The cancer risk level is unacceptable and action is 
required. The total carcinogenic risk values estimated in this study using CRPF method 
were 5.73×10-11, 8.53×10-10, 1.84×10-6, 3.80×10-4, and 6.77×10-4 for minimum, lower 
bound, central tendency, upper bound, and maximum exposure scenarios. The first two 
are below the action limits set by the USEPA, the latter three are above the action limit, 
whereas all were an order of magnitude lower than those estimated by the simple 
addition method.  
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CHAPTER 7 
CONCLUSIONS 
In İzmir drinking water, total carcinogenic risk has been calculated for four 
THM species (chloroform, BDCM, DBCM, and bromoform) and for all three exposure 
routes (ingestion, inhalation and dermal). Exposure pathways of drinking water 
ingestion, inhalation and dermal absorption during bathing, showering, dish and hand 
washing were included. 
Traditional risk assessments for drinking water often considered only ingestion 
exposure to toxic chemicals. In this study, inhalation was found as the principal 
exposure route. The next route was ingestion followed by dermal absorption.  In the 
inhalation exposure estimates, uncertainty was reduced because transfer efficiency was 
used for better estimation of volatilization. Similarly, permeability coefficient, 
variability of population characteristics (body weight, skin surface area, age), water 
behavior patterns (consumption water, ingestion rate) in the studied samples were 
integrated in the risk assessment, instead of  using constants, to decrease the 
uncertainty. 
The total risks for carcinogenic THMs were calculated by two methods which were 
simple addition method and CRPF method under five exposure scenarios. We 
concluded that the total carcinogenic risk calculated by additive method was an order of 
magnitude higher than the CRPF method. In Izmir, for minimum and lower bound 
scenarios, the results of the both methods were below the action limit which were 
between 9.28×10-9 - 5.73×10-11. For central tendency scenario, both methods indicated 
that the risks may be considered as low priority. On the other hand upper bound and 
maximum exposure scenarios resulted in different values. Because the total 
carcinogenic risk calculated by the simple addition method was >1×10-3  it was 
unacceptable and requires action. The total carcinogenic risk calculated by CRPF 
method was (>1×10-4) an order of magnitude lower than the simple addition method but 
still in the unacceptable region requiring action. The estimated total risks indicate that 
the local water authority needs to better control the formation of disinfection by-
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products in the treatment plant and at the boosting stations and/or consider process 
modification in the plant. 
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